Tümgör G et al. |
A case of uneventful ABO-incompatible liver transplantation from a deceased donor managed with routine immunosuppressive treatment. |
2014 |
Turk J Gastroenterol |
pmid:25599790
|
Dinçkan A et al. |
Evaluation of the first 100 liver transplantations. |
2008 |
Turk J Gastroenterol |
pmid:18386237
|
Bajetta E et al. |
Merkel cell carcinoma after liver transplantation: a case report. |
2007 May-Jun |
Tumori |
pmid:17679476
|
Vennarecci G et al. |
[Acute liver toxicity of antiretroviral therapy (HAART) after liver transplantation in a patient with HIV-HCV coinfection and associated hepatocarcinoma (HCC)]. |
2003 Jul-Aug |
Tumori |
pmid:12903579
|
Sommerer C et al. |
Design and rationale of the ATHENA study--A 12-month, multicentre, prospective study evaluating the outcomes of a de novo everolimus-based regimen in combination with reduced cyclosporine or tacrolimus versus a standard regimen in kidney transplant patients: study protocol for a randomised controlled trial. |
2016 |
Trials |
pmid:26888217
|
Nashan B et al. |
Evaluating the efficacy, safety and evolution of renal function with early initiation of everolimus-facilitated tacrolimus reduction in de novo liver transplant recipients: Study protocol for a randomized controlled trial. |
2015 |
Trials |
pmid:25873064
|
Snyder SH et al. |
Neural actions of immunophilin ligands. |
1998 |
Trends Pharmacol. Sci. |
pmid:9509898
|
Liu J |
FK506 and ciclosporin: molecular probes for studying intracellular signal transduction. |
1993 |
Trends Pharmacol. Sci. |
pmid:7692652
|
Chang JY et al. |
FK506 and rapamycin: novel pharmacological probes of the immune response. |
1991 |
Trends Pharmacol. Sci. |
pmid:1710854
|
Cardenas ME et al. |
Signal-transduction cascades as targets for therapeutic intervention by natural products. |
1998 |
Trends Biotechnol. |
pmid:9807840
|
Kunz J and Hall MN |
Cyclosporin A, FK506 and rapamycin: more than just immunosuppression. |
1993 |
Trends Biochem. Sci. |
pmid:7694398
|
|
Report from the 4th International Workshop on Clinical Pharmacology of HIV Therapy. Drug levels in PHAs who receive liver transplants. |
2003 Apr-May |
TreatmentUpdate |
pmid:17216847
|
Farid SG et al. |
Alemtuzumab (Campath-1H)-induced coagulopathy in renal transplantation. |
2009 |
Transplantation |
pmid:19502974
|
Cvetkovic M et al. |
The deleterious effects of long-term cyclosporine A, cyclosporine G, and FK506 on bone mineral metabolism in vivo. |
1994 |
Transplantation |
pmid:7513912
|
Benito N et al. |
Alternariosis after liver transplantation. |
2001 |
Transplantation |
pmid:11740399
|
Gaber AO et al. |
Acute rejection characteristics from a prospective, randomized, double-blind, placebo-controlled multicenter trial of early corticosteroid withdrawal. |
2013 |
Transplantation |
pmid:23423269
|
Boukriche Y et al. |
Severe axonal polyneuropathy after a FK506 overdosage in a lung transplant recipient. |
2001 |
Transplantation |
pmid:11740402
|
Hodge G et al. |
Lymphocytic bronchiolitis is associated with inadequate suppression of blood T-cell granzyme B, IFN-gamma, and TNF-alpha. |
2010 |
Transplantation |
pmid:20559033
|
Yun J et al. |
Bilateral ischemic optic neuropathy in a patient using tacrolimus (FK506) after liver transplantation. |
2010 |
Transplantation |
pmid:20559109
|
Schäffer MR et al. |
Tacrolimus impairs wound healing: a possible role of decreased nitric oxide synthesis. |
1998 |
Transplantation |
pmid:9539093
|
Anderson PO |
Tacrolimus and breastfeeding. |
1998 |
Transplantation |
pmid:9539100
|
Manez R et al. |
Rejection and hepatitis in liver transplants. |
1994 |
Transplantation |
pmid:7517080
|
Jain A et al. |
Delayed introduction of tacrolimus postliver transplant with intravenous mycophenolate mofetil preserves renal function without incurring rejection. |
2014 |
Transplantation |
pmid:25285953
|
Cao W et al. |
Effects of rapamycin on growth factor-stimulated vascular smooth muscle cell DNA synthesis. Inhibition of basic fibroblast growth factor and platelet-derived growth factor action and antagonism of rapamycin by FK506. |
1995 |
Transplantation |
pmid:7532879
|
Migita K et al. |
FK506 potentiates steroid-induced T-cell apoptosis. |
1997 |
Transplantation |
pmid:9371682
|
Fabrega AJ et al. |
Enhancement of allograft survival by single intraoperative donor-specific blood transfusion combined with FK506. |
1993 |
Transplantation |
pmid:7506458
|
Sankary HN et al. |
FK506 treatment in combination with leflunomide in hamster-to-rat heart and liver xenograft transplantation. |
1998 |
Transplantation |
pmid:9798690
|
Koh A et al. |
Supplemental islet infusions restore insulin independence after graft dysfunction in islet transplant recipients. |
2010 |
Transplantation |
pmid:20145529
|
Ito A et al. |
Donor-specific tolerance by perioperative intrathymic injection of bone marrow cells in the rat cardiac allograft model: use of FK506 can shorten the necessary duration of pretransplant intrathymic conditioning. |
1997 |
Transplantation |
pmid:9311715
|
Marcén R et al. |
Lumbar bone mineral density in renal transplant patients on neoral and tacrolimus: a four-year prospective study. |
2006 |
Transplantation |
pmid:16570003
|
Ciancio G et al. |
A randomized long-term trial of tacrolimus/sirolimus versus tacrolimums/mycophenolate versus cyclosporine/sirolimus in renal transplantation: three-year analysis. |
2006 |
Transplantation |
pmid:16570006
|
Barten MJ et al. |
Synergistic effects of sirolimus with cyclosporine and tacrolimus: analysis of immunosuppression on lymphocyte proliferation and activation in rat whole blood. |
2004 |
Transplantation |
pmid:15114077
|
Vennarecci G et al. |
Apoptosis and rejection in rat intestinal transplantation: correlation with FK506 doses and donor specific bone marrow infusions. |
2001 |
Transplantation |
pmid:11455248
|
Schulman SL et al. |
Interaction between tacrolimus and chloramphenicol in a renal transplant recipient. |
1998 |
Transplantation |
pmid:9625026
|
Shackleton CR et al. |
Lack of correlation between the magnitude of preservation injury and the incidence of acute rejection, need for OKT3, and conversion to FK506 in cyclosporine-treated primary liver allograft recipients. |
1995 |
Transplantation |
pmid:7570950
|
Glicklich D et al. |
Chronic renal allograft rejection: no response to mycophenolate mofetil. |
1998 |
Transplantation |
pmid:9721811
|
Eckhoff DE et al. |
The safety and efficacy of a two-dose daclizumab (zenapax) induction therapy in liver transplant recipients. |
2000 |
Transplantation |
pmid:10830224
|
Nakata Y et al. |
Tacrolimus and myocardial hypertrophy. |
2000 |
Transplantation |
pmid:10830241
|
Klein A et al. |
Impact of a pharmaceutical care program on liver transplant patients' compliance with immunosuppressive medication: a prospective, randomized, controlled trial using electronic monitoring. |
2009 |
Transplantation |
pmid:19300186
|
Mazariegos GV et al. |
Weaning of immunosuppression in liver transplant recipients. |
1997 |
Transplantation |
pmid:9020325
|
Marks WH et al. |
Asialoglycoprotein/asialoglycoprotein receptor (AGP-AGPr) interaction is an important mechanism for the uptake of FK506 by hepatocytes. |
1997 |
Transplantation |
pmid:9020333
|
Wennberg L et al. |
The efficacy of CD40 ligand blockade in discordant pig-to-rat islet xenotransplantation is correlated with an immunosuppressive effect of immunoglobulin. |
2005 |
Transplantation |
pmid:15665763
|
Kuypers DR et al. |
Improved adherence to tacrolimus once-daily formulation in renal recipients: a randomized controlled trial using electronic monitoring. |
2013 |
Transplantation |
pmid:23263559
|
Krähenbühl S et al. |
Serious interaction between mibefradil and tacrolimus. |
1998 |
Transplantation |
pmid:9808502
|
White M et al. |
Subclinical inflammation and prothrombotic state in heart transplant recipients: impact of cyclosporin microemulsion vs. tacrolimus. |
2006 |
Transplantation |
pmid:17006323
|
Peduto G et al. |
Long-term host unresponsiveness to encapsulated xenogeneic myoblasts after transient immunosuppression. |
2000 |
Transplantation |
pmid:10919579
|
Aisa Y et al. |
Effects of immunosuppressive agents on magnesium metabolism early after allogeneic hematopoietic stem cell transplantation. |
2005 |
Transplantation |
pmid:16278584
|
Yoshimura N et al. |
A case report of pregnancy in renal transplant recipient treated with FK506 (tacrolimus). |
1996 |
Transplantation |
pmid:8633388
|
Tanaka J et al. |
The immunosuppressive agent FK506 enhances the cytolytic activity of inhibitory natural killer cell receptor (CD94/NKG2A)-expressing CD8 T cells. |
2005 |
Transplantation |
pmid:16378079
|
Dharancy S et al. |
Elevated interleukin-4 expression in severe recurrent hepatitis C virus after liver transplantation. |
2007 |
Transplantation |
pmid:17460561
|